0R34

Johnson & Johnson · LSE:0R34

269.72 USD−4.70 −1.71%

Johnson & Johnson (LSE:0R34) last traded at 269.72 USD, down 1.71% on the day. Over the past year the stock is up 43.42%. Its 52-week range is 185.60 to 282.40. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open270.34

Day range267.43 – 275.00

52-week range185.60 – 282.40

Volume23.19 K

Average volume (10 days)12.07 K

Market cap657.68 B

P/E40.92

EPS (TTM)6.59

Dividend yield1.93%

Beta (1 year)0.5978

Revenue (TTM)99.35 B

Employees140.80 K

Performance

+2.10%1 week

+4.00%1 month

+5.74%3 months

+19.33%6 months

+30.58%Year to date

+43.42%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026
Over 100 of the 600-plus medicines listed by NPPA do not show a drop in pricesBusiness Line · 29 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.